Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Breakthrough in breast cancer treatment with FDA approval of fam-trastuzumab deruxtecan-nxki (Enhertu) for HER2-low and HER2-ultralow metastatic breast cancer.